HOME >> MEDICINE >> NEWS
Robotic surgery-stenting combo opens coronary arteries, speeds recovery

Combining robotically assisted coronary artery bypass surgery (CABG) with stented angioplasty shows promise for treating extensive coronary artery disease, researchers reported at the American Heart Association Scientific Sessions 2005.

"The minimally invasive procedure effectively bypassed or opened blocked arteries in all 27 patients, an outcome as good or better than you would expect with open chest surgery," said Marc R. Katz, M.D., lead author of the study and chief of cardiac surgery and director of the Virginia Transplant Center at Henrico Doctors' Hospital in Richmond.

"The patients stayed in the hospital an average of only two and a half days, compared with five or six days for conventional CABG surgery," Katz said. "And they were back to work in a week or so, compared with the usual six to 12 weeks."

The study involved patients with multi-vessel coronary disease, including obstruction of the left anterior descending coronary artery (LAD), the main artery in the front of the heart.

During the closed-chest bypass procedure, the left internal mammary artery (in the chest) was harvested. Doctors then sutured the mammary artery to the obstructed LAD, bypassing the obstruction, all done endoscopically.

During the angioplasty procedure, doctors used stents (mesh tubes) to unblock other arteries and then prop them open.

"Using the left internal mammary artery to bypass the LAD is the one thing we can do for patients with coronary artery disease that has a proven survival advantage," Katz said. "Here is a way to accomplish that and also open other vessels in a very minimally invasive way."

Robotic surgery involves making three small incisions, each about 1 cm ( inch) long, in the left side of the patient's chest. A 3-D scope with 10x magnification is inserted in the middle port, with the robotic right and left arms in the other ports. The daVinci robotic system is a powerful computer interface that al
'"/>

Contact: Carole Bullock or Karen Astle
carole.bullock@heart.org
214-706-1396
American Heart Association
16-Nov-2005


Page: 1 2

Related medicine news :

1. Springer debuts Journal of Robotic Surgery
2. Robotic treadmill training helps retrain brain, improves walking
3. Robotic technique shows promise in weight-loss surgery, Stanford study finds
4. Radiation therapy combo cures prostate cancer long-term
5. Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders
6. Drug combo improves survival in patients with COPD
7. Gold nanoparticles, radiation combo may slow Alzheimers
8. New study: Drug combo against AIDS-related infections also prevents malaria
9. PRESERVE- 2-year study of initial combo therapy with nateglinide or glyburide + metformin
10. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
11. Nanomedicine opens the way for nerve cell regeneration

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... ... Salveo for life, a company that distributes an effervescent lime-flavored drink called ... part of its presence to expand its market reach. , Using a formula developed ... nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, whilst supporting ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats ... of its owner and founder. As Oat is recognized globally as one of the ... personally as he believes it is a move to sow the seed of good ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events for its annual meeting ... family, friends, and community. “Coming Home 2017” will be held on Friday ...
(Date:1/21/2017)... Rosa, CA (PRWEB) , ... January 21, 2017 ... ... the opening of its new medical office in Petaluma, located at 167 Lynch ... casting room, access to SRO sports medicine and rehabilitation services and ...
(Date:1/21/2017)... ... January 21, 2017 , ... The ... Dr. Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Dr. Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 2017 ARMO BioSciences, Inc., a late-stage immuno-oncology ... Company,s lead investigational immuno-oncology drug AM0010 (PEGylated Interleukin-10) at ... Society of Clinical Oncology (ASCO), taking place January 19-21, ... "AM0010 induces the expansion of novel ... cells in the blood and tumors of our patients," ...
(Date:1/21/2017)... Research and Markets has announced the addition of the "Advanced ... End User - Forecast to 2025" report to their offering. ... The Global Advanced ... around 7.8% over the next decade to reach approximately $330.70 billion ... markets for Advanced Drug Delivery across all the given segments on ...
(Date:1/20/2017)... DUBLIN , Jan 20, 2017 ... Laboratory Testing Market By Type ([CBC, HGB/HCT, BMP, BUN Creatinine, Electrolyte ... Panel), By End-use, And Segment Forecasts, 2013 - 2024" report ... ... USD 198.5 billion by 2024 Introduction of innovative solutions ...
Breaking Medicine Technology:
Cached News: